临床营养市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球临床营养市场价值为 586 亿美元，预计将以 10.9% 的复合年增长率成长，到 2034 年达到 1,612 亿美元。

癌症、糖尿病、胃肠道疾病和肾臟病等慢性疾病常导致营养吸收障碍，增加营养需求。因此，临床营养在患者復健和疾病管理中发挥着至关重要的作用，并推动持续的需求。

婴儿营养需求不断增加

2024年，婴儿营养品市场占据了相当大的份额，这得益于出生率上升、早产率上升以及人们对早期营养重要性的认识不断增强。婴儿配方奶粉用于补充或替代母乳餵养，尤其是在工作家庭和出现医疗併发症的情况下。

儿科采用率不断提高

2025-2034年期间，儿科市场将以可观的复合年增长率成长。对于胃肠道疾病、囊性纤维化和神经系统疾病患者，营养支持至关重要，因为这些疾病患者的常规食物摄取量可能不足。随着护理人员和儿科医生意识的增强，对即食儿科配方奶粉和针对特定疾病的营养品的需求持续增长。

代谢紊乱盛行率不断上升

代谢紊乱领域在2024年创造了可观的收入。苯酮尿症（PKU）、枫糖尿病和其他先天性代谢异常等疾病需要终生饮食管理，通常透过医学营养进行。製造商正在开发蛋白质改质和氨基酸配方，以满足这些独特的需求。

北美将成为利润丰厚的地区

2024年，北美临床营养市场占据强劲份额，这得益于其完善的医疗基础设施、更高的诊断率以及强大的保险覆盖率。美国在该地区处于领先地位，医院、长期照护中心和家庭医疗保健机构的需求不断增长。产品创新和个人化营养正日益受到关注，尤其是在慢性病管理和术后復原领域。

临床营养市场的主要参与者有雀巢健康科学、百特、巴斯夫、荷美尔食品、费森尤斯卡比、雅培（雅培营养）、达能、基立福集团、百利高、美赞臣（利洁时）、明治控股、Hero Nutritionals、Aculife Healthcare 和 B. Braun。

为了巩固市场地位，临床营养领域的公司正专注于研发符合现代医疗方案的专用和针对特定疾病的产品。与医院和医疗保健提供者建立策略合作伙伴关係正在扩大覆盖范围，同时部署数位化工具来追踪患者治疗结果并提高依从性。各公司也透过在地化生产和客製化行销策略瞄准新兴经济体。随着领导企业寻求扩大产品组合和全球影响力，併购活动依然频繁。

目录

第一章：方法论与范围

第 2 章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 慢性病盛行率上升
    • 营养不良发生率高
    • 营养科学的进步
    • 意识增强，医疗保健支出增加
  • 产业陷阱与挑战
    • 先进配方成本高
    • 有限的报销政策
  • 市场机会
    • 家庭医疗保健领域的扩张
    • 数位健康整合
• 成长潜力分析
• 技术格局
  • 当前的技术趋势
  • 新兴技术
• 临床营养的供应链分析
• 膳食补充剂的使用场景
• 监管格局
• 未来市场趋势
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 伙伴关係与协作
  • 新产品发布

第五章：市场估计与预测：按产品，2021 - 2034 年

• 主要趋势
• 婴儿营养
  • 牛奶基
  • 大豆基
  • 有机配方
  • 其他婴儿配方奶粉
• 肠内营养
  • 标准成分
  • 疾病特异性组成
  • 元素公式
  • 其他肠内配方
• 肠外营养
  • 胺基酸
  • 脂肪
  • 碳水化合物
  • 维生素和矿物质
  • 其他肠外配方

第六章：市场估计与预测：依消费者划分，2021 - 2034 年

• 主要趋势
• 儿科
• 成人

第七章：市场估计与预测：按应用，2021 - 2034

• 主要趋势
• 营养不良
• 癌症营养
• 代谢紊乱
• 神经系统疾病
• 胃肠道疾病
• 其他应用

第八章：市场估计与预测：按剂型，2021 - 2034

• 主要趋势
• 粉末
• 液体
• 坚硬的

第九章：市场估计与预测：按配销通路，2021 - 2034 年

• 主要趋势
• 线下通路
  • 医院药房
  • 零售药局
  • 其他线下通路
• 线上通路

第 10 章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：公司简介

• Abbott (Abbott Nutrition)
• Aculife Healthcare
• B Braun
• BASF
• Baxter
• Danone
• Fresenius Kabi
• Grifols
• Hero Nutritionals
• Hormel Foods
• Mead Johnson (Reckitt Benckiser)
• Meiji Holdings
• Nestle Health Science
• Perrigo

The Global Clinical Nutrition Market was valued at USD 58.6 billion in 2024 and is estimated to grow at a CAGR of 10.9% to reach USD 161.2 billion by 2034.

Chronic conditions such as cancer, diabetes, gastrointestinal disorders, and kidney disease often lead to impaired nutrient absorption and increased nutritional needs. As a result, clinical nutrition plays a vital role in patient recovery and disease management, driving consistent demand.

Rising Demand for Infant Nutrition

The infant nutrition segment held a substantial share in 2024, driven by rising birth rates, increasing rates of preterm births, and growing awareness of the importance of early-life nutrition. Infant formulas are used to supplement or replace breastfeeding, especially in working households and in cases of medical complications.

Growing Adoption Among Pediatrics

The pediatric segment will grow at a decent CAGR during 2025-2034. Nutritional support is essential in cases of gastrointestinal disorders, cystic fibrosis, and neurological impairments, where regular food intake may be insufficient. Demand for ready-to-use pediatric formulas and condition-specific nutrition continues to grow as awareness among caregivers and pediatricians increases.

Increasing Prevalence of Metabolic Disorders

The metabolic disorders segment generated significant revenues in 2024. Conditions like phenylketonuria (PKU), maple syrup urine disease, and other inborn errors of metabolism require lifelong dietary management, often through medical nutrition. Manufacturers are developing protein-modified and amino acid-based formulas to cater to these unique requirements.

North America to Emerge as a Lucrative Region

North America clinical nutrition market held a robust share in 2024, driven by a well-established healthcare infrastructure, higher diagnosis rates, and strong insurance coverage. The U.S. leads the region, with increasing demand across hospitals, long-term care centers, and home healthcare settings. Product innovation and personalized nutrition are gaining traction, especially in the context of chronic disease management and post-surgical recovery.

Major players in the clinical nutrition market are Nestle Health Science, Baxter, BASF, Hormel Foods, Fresenius Kabi, Abbott (Abbott Nutrition), Danone, Grifols SA, Perrigo, Mead Johnson (Reckitt Benckiser), Meiji Holdings, Hero Nutritionals, Aculife Healthcare, and B. Braun.

To solidify their market presence, companies in the clinical nutrition space are focusing on R&D to develop specialized and condition-specific products that align with modern medical protocols. Strategic partnerships with hospitals and healthcare providers are expanding access, while digital tools deploy to track patient outcomes and improve compliance. Firms are also targeting emerging economies through localized manufacturing and tailored marketing strategies. Mergers and acquisitions remain common, as leading players seek to expand their product portfolios and global reach.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product
  • 2.2.3 Consumer
  • 2.2.4 Application
  • 2.2.5 Dosage Form
  • 2.2.6 Distribution channel
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of chronic diseases
    • 3.2.1.2 High incidence of malnutrition
    • 3.2.1.3 Advancements in nutritional science
    • 3.2.1.4 Growing awareness and healthcare spending
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced formulations
    • 3.2.2.2 Limited reimbursement policies
  • 3.2.3 Market opportunities
    • 3.2.3.1 Expansion of the home healthcare sector
    • 3.2.3.2 Digital health integration
• 3.3 Growth potential analysis
• 3.4 Technology landscape
  • 3.4.1 Current technological trends
  • 3.4.2 Emerging technologies
• 3.5 Supply chain analysis for clinical nutrition
• 3.6 Dietary supplements usage scenario
• 3.7 Regulatory landscape
• 3.8 Future market trends
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Merger and acquisition
  • 4.6.2 Partnership and collaboration
  • 4.6.3 New product launches

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Infant nutrition
  • 5.2.1 Milk-based
  • 5.2.2 Soy-based
  • 5.2.3 Organic formula
  • 5.2.4 Other infant formulas
• 5.3 Enteral nutrition
  • 5.3.1 Standard composition
  • 5.3.2 Disease-specific composition
  • 5.3.3 Elemental formulas
  • 5.3.4 Other enteral formulas
• 5.4 Parenteral nutrition
  • 5.4.1 Amino acids
  • 5.4.2 Fats
  • 5.4.3 Carbohydrates
  • 5.4.4 Vitamins & minerals
  • 5.4.5 Other parenteral formulas

Chapter 6 Market Estimates and Forecast, By Consumer, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Pediatric
• 6.3 Adult

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Malnutrition
• 7.3 Cancer nutrition
• 7.4 Metabolic disorders
• 7.5 Neurological diseases
• 7.6 Gastrointestinal disorder
• 7.7 Other applications

Chapter 8 Market Estimates and Forecast, By Dosage Form, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Powder
• 8.3 Liquid
• 8.4 Solid

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Offline channels
  • 9.2.1 Hospital pharmacies
  • 9.2.2 Retail pharmacies
  • 9.2.3 Other offline channels
• 9.3 Online channels

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 Abbott (Abbott Nutrition)
• 11.2 Aculife Healthcare
• 11.3 B Braun
• 11.4 BASF
• 11.5 Baxter
• 11.6 Danone
• 11.7 Fresenius Kabi
• 11.8 Grifols
• 11.9 Hero Nutritionals
• 11.10 Hormel Foods
• 11.11 Mead Johnson (Reckitt Benckiser)
• 11.12 Meiji Holdings
• 11.13 Nestle Health Science
• 11.14 Perrigo